Search research articles
Contact Us
Filters
Showing results (1-10 of 64) with videos related to
Page
of 7
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
March 12, 2005
[Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?]
S M Bode-Böger
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
September 30, 2005
Organic nitrates in cardiovascular disease
S M Bode-Böger, G Kojda
Annual Review of Pharmacology and Toxicology
|
March 27, 2001
The clinical pharmacology of L-arginine
R H Böger, S M Bode-Böger
Seminars in Thrombosis and Hemostasis
|
December 29, 2000
Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases
R H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten
|
August 1, 1997
[Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use]
R H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten
|
January 1, 1996
[Restenosis after percutaneous transluminal angioplasty: I. Etiology and clinical significance]
H Alfke, R H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten
|
January 1, 1996
[Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention]
R H Böger, S M Bode-Böger, H Alfke
Der Internist
|
July 1, 1995
[Comments on the contribution by Prof. Dr. S. H. Hohnloser. Sotalol]
S M Bode-Böger, R H Böger, J C Frölich
Medizinische Klinik (Munich, Germany : 1983)
|
September 15, 1995
[Intravenous immunoglobulins. Basic principles, selection criteria and indications for preventive and therapeutic administration]
R H Böger, S M Bode-Böger, J C Frölich
Der Internist
|
May 1, 1997
[Anti-arteriosclerosis effects due to stimulation of endogenous nitric oxide synthesis]
S M Bode-Böger, R H Böger, J C Frölich
Page
of 7
Search research articles
Search
Showing results (1-10 of 64) with videos related to
Sort By:
Page
of 7
Deutsche Medizinische Wochenschrift (1946)
|
March 12, 2005
[Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?]
S M Bode-Böger
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
September 30, 2005
Organic nitrates in cardiovascular disease
S M Bode-Böger, G Kojda
Annual Review of Pharmacology and Toxicology
|
March 27, 2001
The clinical pharmacology of L-arginine
R H Böger, S M Bode-Böger
Seminars in Thrombosis and Hemostasis
|
December 29, 2000
Asymmetric dimethylarginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases
R H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten
|
August 1, 1997
[Endothelial dysfunction in peripheral arterial occlusive disease: from basic research to clinical use]
R H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten
|
January 1, 1996
[Restenosis after percutaneous transluminal angioplasty: I. Etiology and clinical significance]
H Alfke, R H Böger, S M Bode-Böger
VASA. Zeitschrift Fur Gefasskrankheiten
|
January 1, 1996
[Restenosis after percutaneous transluminal angioplasty: II. Possibilities for pharmacologic intervention]
R H Böger, S M Bode-Böger, H Alfke
Der Internist
|
July 1, 1995
[Comments on the contribution by Prof. Dr. S. H. Hohnloser. Sotalol]
S M Bode-Böger, R H Böger, J C Frölich
Medizinische Klinik (Munich, Germany : 1983)
|
September 15, 1995
[Intravenous immunoglobulins. Basic principles, selection criteria and indications for preventive and therapeutic administration]
R H Böger, S M Bode-Böger, J C Frölich
Der Internist
|
May 1, 1997
[Anti-arteriosclerosis effects due to stimulation of endogenous nitric oxide synthesis]
S M Bode-Böger, R H Böger, J C Frölich
Page
of 7